Based on these data, we suggest that YKL-40 plays a pivotal role in AP, irrespective of the severity of the disease, possibly by regulating key pathways and processes within the respective pancreatic microenvironment during AP. The gene discussed is CHI3L1; the disease is alkaline phosphatase measurement.